Navigation Links
Quantel Medical Announces Two New Ultrasound Probes at ASCRS
Date:4/20/2013

SAN FRANCISCO, April 20, 2013 /PRNewswire/ -- Quantel Medical today announced the introduction of two new diagnostic ultrasound probes to their flagship ultrasound platform, Aviso™, at the American Society of Cataract and Refractive Surgery annual meeting. The new probes offer improved diagnosis capability for posterior and anterior segment ophthalmic conditions.

The new 50 MHz high-frequency ultrasound biomicroscope (UBM) probe now includes a state-of-the art magnetic transducer. The scanning motion in the ultrasound is controlled through magnetic fields instead of mechanical movements as in previous versions. This new technology offers a faster scanning process, which has increased the image resolution by one-third. Additional benefits include a lighter-weight design and less vibration when performing an ultrasound, reducing fatigue to the user. The reliability and durability of the probe is also improved by eliminating mechanical components.

The new 10 MHz B-scan probe offers similar benefits for posterior pole diagnosis. This B-scan probe provides superior image quality for viewing and assessment of the detailed structures in the vitreous and the orbital wall. Increased image acquisition rate allows for high-definition characterization of ocular structures and their movements. The dynamic gain functionality of the 10 MHz allows users to adjust settings to find the optimal tissue differentiation in the image, allowing for more visual clarity and better understanding of the condition of the eye.

"These two product introductions reflect Quantel's commitment to developing the most robust and advanced ultrasound technology available to ophthalmologists," stated Mr. Jean-Marc Gendre , CEO of Quantel Medical. "Image quality and ease of acquisition are two critical features that we strive to improve and provide to our customers."

The Aviso ultrasound platform is configurable to include the new 50 MHz and 10 MHz probes, as well as biometry and Standardized echography modules. Quantel Medical's line of posterior and anterior segment ultrasound diagnostic systems provide eye care physicians of all specialties with a critical tool for understanding pathology and obtaining accurate measurements.

About Quantel Medical
Founded in 1993 and headquartered in Clermont-Ferrand, France, Quantel Medical is a global ophthalmic medical device company dedicated to developing leading technologies to improve the treatment of ocular diseases. Quantel Medical has a strong emphasis in research and development, resulting in many first-to-market product introductions, and a comprehensive product portfolio of diagnostic ultrasound and surgical lasers for ophthalmologists. The products are available through direct sales operations in the U.S. and France, and through independent distributors in over 80 countries.

Quantel Medical is a division of Quantel (QUA:EN), a world-wide leader in the development of solid-state lasers for scientific and industrial applications.

www.quantel-medical.com


'/>"/>
SOURCE Quantel Medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. QUANTEL Medical Signs Global Licensing Agreement with IRIDEX
2. Quantel Medical Receives FDA Clearance for new Vitra Multispot Laser System
3. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
4. Medical Device Developers - Network at BIOMEDevice Boston Next Week
5. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
6. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
7. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
8. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
9. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
10. Essential Medical Dismisses Patent Case against Masimo and Cercacor
11. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):